# Transplantation

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/transplantation/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,082,457 |
| h-index | 279 |
| Homepage | https://journals.lww.com/transplantjournal/pages/default.aspx |
| Open Access | false |
| ISSN-L | 0041-1337 |
| ISSNs | 0041-1337,1534-6080 |
| OpenAlex ID | https://openalex.org/S11564597 |
| Publisher | Wolters Kluwer |
| Works | 58,430 |

## Journal papers

Showing 12 of 123.

- [DELAYED GRAFT FUNCTION: RISK FACTORS AND IMPLICATIONS FOR RENAL ALLOGRAFT SURVIVAL1](https://scholariq.org/papers/delayed-graft-function-risk-factors-and-implications-for-renal-allograft/)
- [Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors1](https://scholariq.org/papers/donor-characteristics-associated-with-reduced-graft-survival-an-approach-to/)
- [MULTICENTER RANDOMIZED TRIAL COMPARING TACROLIMUS (FK506) AND CYCLOSPORINE IN THE PREVENTION OF RENAL ALLOGRAFT REJECTION1](https://scholariq.org/papers/multicenter-randomized-trial-comparing-tacrolimus-fk506-and-cyclosporine-in-the/)
- [KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation](https://scholariq.org/papers/kdigo-clinical-practice-guideline-on-the-evaluation-and-management-of-candidates/)
- [PORTAL VEIN THROMBOSIS IN ADULTS UNDERGOING LIVER TRANSPLANTATION](https://scholariq.org/papers/portal-vein-thrombosis-in-adults-undergoing-liver-transplantation/)
- [NEW-ONSET DIABETES AFTER TRANSPLANTATION: 2003 INTERNATIONAL CONSENSUS GUIDELINES1](https://scholariq.org/papers/new-onset-diabetes-after-transplantation-2003-international-consensus/)
- [A RANDOMIZED ACTIVE-CONTROLLED TRIAL OF MYCOPHENOLATE MOFETIL IN HEART TRANSPLANT RECIPIENTS1](https://scholariq.org/papers/a-randomized-active-controlled-trial-of-mycophenolate-mofetil-in-heart/)
- [Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial](https://scholariq.org/papers/conversion-from-calcineurin-inhibitors-to-sirolimus-maintenance-therapy-in-renal/)
- [Rates and Risk Factors for Nonadherence to the Medical Regimen After Adult Solid Organ Transplantation](https://scholariq.org/papers/rates-and-risk-factors-for-nonadherence-to-the-medical-regimen-after-adult-solid/)
- [DELAYED GRAFT FUNCTION, ACUTE REJECTION, AND OUTCOME AFTER CADAVER RENAL TRANSPLANTATION](https://scholariq.org/papers/delayed-graft-function-acute-rejection-and-outcome-after-cadaver-renal/)
- [Fetal Mesenchymal Stem-Cell Engraftment in Bone after In Utero Transplantation in a Patient with Severe Osteogenesis Imperfecta](https://scholariq.org/papers/fetal-mesenchymal-stem-cell-engraftment-in-bone-after-in-utero-transplantation/)
- [Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma](https://scholariq.org/papers/sirolimus-use-in-liver-transplant-recipients-with-hepatocellular-carcinoma/)

## Journal top topics

Showing 8 of 25.

- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Organ Transplantation Techniques and Outcomes](https://scholariq.org/topics/organ-transplantation-techniques-and-outcomes/)
- [Organ Donation and Transplantation](https://scholariq.org/topics/organ-donation-and-transplantation/)
- [Transplantation: Methods and Outcomes](https://scholariq.org/topics/transplantation-methods-and-outcomes/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)
- [Organ and Tissue Transplantation Research](https://scholariq.org/topics/organ-and-tissue-transplantation-research/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Xenotransplantation and immune response](https://scholariq.org/topics/xenotransplantation-and-immune-response/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.